Literature DB >> 6275107

Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species.

J Deschamps, R Kettmann, A Burny.   

Abstract

Taking advantage of the existence of a unique SacI restriction site in the long terminal repeats of the integrated bovine leukemia virus proviral DNA isolated from a bovine tumor, the total viral information (about 9.2 kilobases) was cloned in the lambdoid vector lambda WES. lambda B. Use of this cloned bovine leukemia virus DNA allowed us, for the first time, to definitely rule out the existence of any endogenous bovine leukemia virus sequence in the bovine, ovine, caprine, murine, feline, chicken, or human genomes. These data prove the absence of acquired cellular information in the provirus that has given rise to a tumor.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6275107      PMCID： PMC256666     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  Structure of the Abelson murine leukemia virus genome.

Authors:  A Shields; S Goff; M Paskind; G Otto; D Baltimore
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

2.  Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation.

Authors:  M Roussel; S Saule; C Lagrou; C Rommens; H Beug; T Graf; D Stehelin
Journal:  Nature       Date:  1979-10-11       Impact factor: 49.962

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  A rapid method for extracting DNA from agarose gels.

Authors:  M Finkelstein; T H Rownd
Journal:  Plasmid       Date:  1978-09       Impact factor: 3.466

5.  EK2 derivatives of bacteriophage lambda useful in the cloning of DNA from higher organisms: the lambdagtWES system.

Authors:  P Leder; D Tiemeier; L Enquist
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

6.  Cloning human fetal gamma globin and mouse alpha-type globin DNA: preparation and screening of shotgun collections.

Authors:  F R Blattner; A E Blechl; K Denniston-Thompson; H E Faber; J E Richards; J L Slightom; P W Tucker; O Smithies
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728

7.  Integration of bovine leukemia virus DNA in the bovine genome.

Authors:  R Kettmann; M Meunier-Rotival; J Cortadas; G Cuny; J Ghysdael; M Mammerickx; A Burny; G Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Amino-terminal sequence of bovine leukemia virus major internal protein: homology with mammalian type C virus p30 structural proteins.

Authors:  S Oroszlan; T D Copeland; L E Henderson; J R Stephenson; R V Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

9.  Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state.

Authors:  G S Payne; S A Courtneidge; L B Crittenden; A M Fadly; J M Bishop; H E Varmus
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

10.  Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic.

Authors:  R Kettmann; Y Cleuter; M Mammerickx; M Meunier-Rotival; G Bernardi; A Burny; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205
View more
  27 in total

1.  Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins.

Authors:  R Z Mamoun; M Morisson; N Rebeyrotte; B Busetta; D Couez; R Kettmann; M Hospital; B Guillemain
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA.

Authors:  R Z Mamoun; T Astier-Gin; R Kettmann; J Deschamps; N Rebeyrotte; B J Guillemain
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Identification and some biochemical properties of the major XBL gene product of bovine leukemia virus.

Authors:  N Sagata; J Tsuzuku-Kawamura; M Nagayoshi-Aida; F Shimizu; K Imagawa; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

4.  Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus.

Authors:  D Milan; J F Nicolas
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.

Authors:  Sinisa Novakovic; Earl T Sawai; Kathryn Radke
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.

Authors:  M L Mirsky; C A Olmstead; Y Da; H A Lewin
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus.

Authors:  N Sagata; T Yasunaga; Y Ogawa; J Tsuzuku-Kawamura; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 8.  Reflections on viruses and cancer.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

9.  Episodic occurrence of antibodies against the bovine leukemia virus Rex protein during the course of infection in sheep.

Authors:  M A Powers; D Grossman; L C Kidd; K Radke
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences.

Authors:  R Kettmann; J Deschamps; Y Cleuter; D Couez; A Burny; G Marbaix
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.